(Q72366254)

English

Treatment with a beta-blocker with beta 2-agonism improves glucose and lipid metabolism in essential hypertension

scientific article published on 01 April 1994

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8159103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8159103%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 October 2019

title

Treatment with a beta-blocker with beta 2-agonism improves glucose and lipid metabolism in essential hypertension (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8159103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8159103%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 October 2019

main subject

essential hypertension

1 reference

A Haenni

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8159103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8159103%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 October 2019

H Lithell

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8159103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8159103%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 October 2019

publication date

1 April 1994

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8159103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8159103%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

Europe PubMed Central

PubMed publication ID

8159103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8159103%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 October 2019

volume

43

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8159103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8159103%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 October 2019

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8159103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8159103%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 October 2019

page(s)

455-461

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8159103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8159103%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 October 2019

Identifiers

DOI

10.1016/0026-0495(94)90076-0

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8159103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8159103%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 October 2019

PubMed publication ID

8159103

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8159103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8159103%20AND%20SRC:MED&resulttype=core&format=json

(Q72366254)

Treatment with a beta-blocker with beta 2-agonism improves glucose and lipid metabolism in essential hypertension

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)